Mediso Medical Imaging System (MEDISO)
Mediso have been working in the field of nuclear and molecular medicine since 1990 with a profile of development, manufacturing, sales and servicing of multi-modality in-vivo imaging systems. The company offers complete solutions from hardware design to evaluation and quantification software, both for clinical patient care and high-level life science research into all animal models in between rodents and primates. Besides the unique triple-modality clinical SPECT/CT/PET hybrid AnyScan® as well as the triple headed TRIO SPECT/CT system, Mediso launched the world's first pre-clinical integrated PET/MRI and SPECT/MRI cameras as members of the nanoScan® high-end small animal imager family, consisting of SPECT, PET, CT and MRI modalities.
Products are sold worldwide directly and through a network of distributors, with over 1250 imaging systems operating in more than 90 countries around the globe. From 2016 new 3T and 7T cryogen-free magnets have been integrated into the nanoScan® product line, contributing to the about 200 commissioned systems, including the largest install base of 25+ integrated PET/MRI cameras, highlighting Mediso's preclinical imaging market leader position.
Besides the Company runs successfully two complex clinical diagnostic, research and educational centres and offers clinical and evaluation software trainings for the international medical community.